Elsevier Announces New Journal for 2007
Primary Care Diabetes
London, 30 November 2006 – Elsevier and Primary Care Diabetes Europe are set to launch Primary Care Diabetes, an influential new diabetes journal in February 2007. Primary Care Diabetes, edited by Professor Guy EHM Rutten (Utrecht, The Netherlands) will be published quarterly and provide a valuable new resource for general practitioners/family doctors, nurses and other diabetes primary-care workers, by publishing original articles and high-quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research, epidemiology and other related areas.
Primary Care Diabetes is the official journal of Primary Care Diabetes Europe. Guy Rutten is joined by Associate Editors Kamlesh Khunti (UK), Neil Munro (UK) and KM Venkat Narayan (USA) and an international Editorial Board. "Primary Care Diabetes will be an important vehicle for the dissemination of high-quality applied research related to diabetes prevention and control in primary care" commented the editors of Primary Care Diabetes. "Our goal is to promote the implementation of evidence-based diabetes for all those working in a primary care setting and at the primary/secondary care interface."
Please visit the journal website at www.primary-care-diabetes.com to view free Preview Issue content. Subscribers will have full access to each issue as well as articles in press on the journal’s website. Primary Care Diabetes will also be accessible through Elsevier’s online database, ScienceDirect, the world's largest electronic collection of science, technology and medicine full text and bibliographic information.
# # #
About Primary Care Diabetes Europe
PCD Europe exists to provide a focal point for primary care clinicians and their patients. Its purpose is to promote high standards of care throughout Europe. Emphasis is placed on incorporating evidence based medicine into daily practice as well as promoting diabetes education and research in primary care.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+44 (0) 1865 8438 23